Monday, June 22, 2020

How COVID-19 helped Netanyahu beat Benny Gantz for Israeli prime ministership

This article is by

Share this article

Article Contributor(s)

Kanika Bajaj

Article Title

How COVID-19 helped Netanyahu beat Benny Gantz for Israeli prime ministership

Publisher

Global Views 360

Publication Date

June 22, 2020

URL

Benjamin Netanyahu and Benny Gantz

Benjamin Netanyahu and Benny Gantz | Source: US Department of State via Wikimedia

In March 2020, when COVID-19 was causing the near collapse of health systems across the world, Israel had just voted third time in the parliamentary election for the third time in less than a year. This was so because no political party was able to muster the majority in Knesset (Israeli parliament) after earlier elections in April 2019 and Sept 2019. Benjamin Netanyahu has been acting Prime minister since the time when he went for the dissolution of Knesset December 2018 with a hope of securing an extended majority for his right wing coalition. However he failed to secure even the simple majority in three elections on April 19, Sept 19, and March 20. Then came the COVID-19 and he sensed an opportunity to make a comeback from the brink of political disaster to reclaim the prime ministership of Israel.

The COVID-19 pandemic tested the Israeli citizens just like the other countries and  Benjamin Netanyahu kept on telling that unless it is effectively controlled, there will be devastation not seen since the Middle Ages. He also stressed that even the First world countries such as the US and UK are at the brink of losing control. Many Israelis expressed admiration towards Netanyahu’s quick response to the pandemic which helped to contain the pandemic in earlier stages. They flattened their curve by shutting down public places such as parks, schools, educational institutions, and the hotspot areas. He followed two stage strategies — first, to locate and isolate the infected population and then to engage the healthy population in economic activities during the conditions of a semi-lockdown. These steps were taken to save the economy. His plan also carried a huge amount of tests in the hope that it could be established that some people were developing antibodies to resist the virus and could safely be “freed” from isolation. Although the steps being acknowledged, they still raised a lot of questions against Netanyahu. He was supposed to be facing charges for breach of trust and bribery in the month of March. The court shutdown ordered by Israeli Law minister delayed Netanyahu’s charges by two months. Israel also used the cell phone of citizens to monitor their movement to track the spread of pandemic for which he was criticised for breaching the citizen’s privacy. Yohanan Plesner, the president of the Israel Democracy Institute said that Israelis trust the Shin Bet to protect them and not to abuse that trust, and the cellphone monitoring may have serious long-term effects on that trust. Netanyahu, however, defended himself with usual combativeness by stating that the courts were under a temporary shutdown and he has received permission from the General Attorney for cellphone usage data which was valid for 14 days. He also said “If the Shin Bet is to

infringe on our basic privacy, they could have done it many years ago”.

After managing to convince the citizens that he had handled the COVID-19 situation effectively, he quickly approached the rival Benny Gantz with a proposal to form an “emergency unity government”. As part of the deal he offered to share the power with Gantz’s Blue and White party for three years during which Netanyahu was to be prime minister and Benny Gants Dy prime minister for the first 18 months and the role reversal afterwards. He kept on harping the disastrous consequences of the virus and mentioned “It could affect 60-80% of the population” and said “nobody knows” how devastating the virus would ultimately prove. 

It was not easy for Benny Gantz to accept the proposal to align with Netanyahu as his whole campaign was on the issue of never supporting Netanyahu. However Netanyahu, who is acknowledged by friends and foes alike as a shrewd politician willing to go to any extent in safeguarding his own interest, finally won the war of attrition. Benny Gantz accepted the deal offered by Netanyahu and agreed to let him continue to be the prime minister for the first 18 months of the alliance period. The COVID-19 calamity has effectively turned into an opportunity for Netanyahu to hold on to the power and continue to be the prime minister of Israel.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More